Skip to results

Last updated date

Last updated date

Type (2 selected)

Type

Guidance programme (1 selected)

Guidance programme

Showing 31 to 34 of 34

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Panobinostat for treating multiple myeloma after at least 2 previous treatmentsTA380
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantationTA311
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Bortezomib monotherapy for relapsed multiple myelomaTA129

Results per page

  1. 10
  2. 25
  3. 50
  4. All